Drugs / small extracellular vesicles
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06242379 | May 2024 → Dec 2026 expected | retinitis pigmentosa | Mahidol University | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | small extracellular vesicles | “The first step, production and characterization of GMP-compliant bone marrow mesenchymal stem cell (BM-MSC)-derived small extracellular vesicles (sEVs) has been performed...” NCT06242379 ↗ |
| Known as | sEVs | “The first step, production and characterization of GMP-compliant bone marrow mesenchymal stem cell (BM-MSC)-derived small extracellular vesicles (sEVs) has been performed...” NCT06242379 ↗ |
| Route | Intravitreal | “intravitreal injection of GMP-compliant BM-MSC-derived sEVs” NCT06242379 ↗ |